Gut hormone activity of children born to women with and without gestational diabetes

Pediatric Obesity

Volumn 9, Issue 1, 2014, Pages 53-62

  Chandler Laney, P C ^a   Bush, N C ^a   Rouse, D J ^b   Mancuso, M S ^c   Gower, B A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BROWN UNIVERSITY   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Ghrelin; GLP 1; obesity; PYY

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY;

AFRICAN AMERICAN; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; BODY FAT; CALORIC INTAKE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE ACTION; HUMAN; MALE; MEAL; POSTPRANDIAL STATE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; RESTING ENERGY EXPENDITURE;

GHRELIN; GLP-1; OBESITY; PYY;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES, GESTATIONAL; ENERGY INTAKE; FASTING; FEMALE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; PEDIATRIC OBESITY; PEPTIDE YY; POSTPRANDIAL PERIOD; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84900539713     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/j.2047-6310.2012.00140.x     Document Type: Article

References (45)

1. Boney CM, Verma A, Tucker R, Vohr BR,. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: e290-e296.
2. Chandler-Laney P, Bush N, Granger W, Rouse D, Mancuso M, Gower B,. Overweight status and intrauterine exposure to gestational diabetes are associated with children's metabolic health. Pediatr Obes 2012; 7: 44-52.
3. Gillman MW, Rifas-Shiman S, Berkey CS, Field AE, Colditz GA,. Maternal gestational diabetes, birth weight, and adolescent obesity. Pediatrics 2003; 111: e221-e226.
4. Wiedmer P, Nogueiras R, Broglio F, D'Alessio D, Tschöp MH,. Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab 2007; 3: 705-712.
5. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS,. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-1719.
6. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML,. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709.
7. English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JP,. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 2002; 87: 2984-2987.
8. Lomenick J, Clasey J, Anderson J,. Meal-related changes in ghrelin, peptide YY, and appetite in normal weight and overweight children. Obesity (Silver Spring) 2008; 16: 547-552.
9. Stock S, Leichner P, Wong AC, et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 2005; 90: 2161-2168.
10. Chanoine JP, Mackelvie KJ, Barr SI, Wong AC, Meneilly GS, Elahi DH,. GLP-1 and appetite responses to a meal in lean and overweight adolescents following exercise. Obesity (Silver Spring) 2008; 16: 202-204.
11. Tomasik PJ, Sztefko K, Malek A,. GLP-1 as a satiety factor in children with eating disorders. Horm Metab Res 2002; 34: 77-80.
12. Verdich C, Toubro S, Buemann B, Lysgård Madsen J, Juul Holst J, Astrup A,. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord 2001; 25: 1206-1214.
13. Batterham R, Cohen M, Ellis S, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003; 349: 941-948.
14. le Roux CW, Batterham RL, Aylwin SJ, et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006; 147: 3-8.
15. Higgins P, Fernández J, Goran M, Gower B,. Early ethnic difference in insulin-like growth factor-1 is associated with African genetic admixture. Pediatr Res 2005; 58: 850-854.
16. Johnson RK, Driscoll P, Goran MI,. Comparison of multiple-pass 24-hour recall estimates of energy intake with total energy expenditure determined by the doubly labeled water method in young children. J Am Diet Assoc 1996; 96: 1140-1144.
17. Lloyd B, Ravi P, Mendes N, Klibanski A, Misra M,. Peptide YY levels across pubertal stages and associations with growth hormone. J Clin Endocrinol Metab 2010; 95: 2957-2962.
18. Bellone S, Prodam F, Savastio S, et al. Acylated and unacylated ghrelin levels in normal weight and obese children: influence of puberty and relationship with insulin, leptin and adiponectin levels. J Endocrinol Invest 2012; 35 (2): 191-197.
19. Matthews JN, Altman DG, Campbell MJ, Royston P,. Analysis of serial measurements in medical research. BMJ 1990; 300: 230-235.
20. Ng PC, Lee CH, Lam CW, Wong E, Chan IH, Fok TF,. Plasma ghrelin and resistin concentrations are suppressed in infants of insulin-dependent diabetic mothers. J Clin Endocrinol Metab 2004; 89: 5563-5568.
21. Mittelman SD, Klier K, Braun S, Azen C, Geffner ME, Buchanan TA,. Obese adolescents show impaired meal responses of the appetite-regulating hormones ghrelin and PYY. Obesity (Silver Spring) 2010; 18: 918-925.
22. Misra M, Tsai PM, Mendes N, Miller KK, Klibanski A,. Increased carbohydrate induced ghrelin secretion in obese vs. normal-weight adolescent girls. Obesity (Silver Spring) 2009; 17: 1689-1695.
23. Maffeis C, Surano MG, Cordioli S, Gasperotti S, Corradi M, Pinelli L,. A high-fat vs. a moderate-fat meal in obese boys: nutrient balance, appetite, and gastrointestinal hormone changes. Obesity (Silver Spring) 2010; 18: 449-455.
24. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ,. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 1993; 38: 665-673.
25. Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W,. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab 1993; 76: 912-917.
26. Rask E, Olsson T, Söderberg S, et al. Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care 2001; 24: 1640-1645.
27. Viardot A, Heilbronn LK, Herzog H, Gregersen S, Campbell LV,. Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes. Int J Obes (Lond) 2008; 32: 943-948.
28. Weyer C, Salbe AD, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA,. Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans? Metabolism 2001; 50: 223-230.
29. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR,. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985; 89: 1070-1077.
30. Grandt D, Schimiczek M, Beglinger C, et al. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 1994; 51: 151-159.
31. Larsson LI, Sundler F, Håkanson R,. Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells. Cell Tissue Res 1975; 156: 167-171.
32. Lee HM, Udupi V, Englander EW, Rajaraman S, Coffey RJ, Greeley GH,. Stimulatory actions of insulin-like growth factor-I and transforming growth factor-alpha on intestinal neurotensin and peptide YY. Endocrinology 1999; 140: 4065-4069.
33. Grissa O, Yessoufou A, Mrisak I, et al. Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia. BMC Pregnancy Childbirth 2010; 10: 1-10.
34. Lindsay RS, Westgate JA, Beattie J, et al. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol (Oxf) 2007; 66: 322-328.
35. Manderson JG, Mullan B, Patterson CC, Hadden DR, Traub AI, McCance DR,. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia 2002; 45: 991-996.
36. le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108-114.
37. Beckman LM, Beckman TR, Earthman CP,. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc 2010; 110: 571-584.
38. Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002; 418: 650-654.
39. Tschöp M, Castañeda TR, Joost HG, et al. Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature 2004; 430: 1-3.
40. Batterham R, Cowley M, Small C, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002; 418: 650-654.
41. Morley JE, Levine AS, Grace M, Kneip J,. Peptide YY (PYY), a potent orexigenic agent. Brain Res 1985; 341: 200-203.
42. Corp ES, Melville LD, Greenberg D, Gibbs J, Smith GP,. Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors. Am J Physiol 1990; 259: R317-R323.
43. Hagan MM, Moss DE,. Effect of peptide YY (PYY) on food-associated conflict. Physiol Behav 1995; 58: 731-735.
44. Franke K, Harder T, Aerts L, et al. 'Programming' of orexigenic and anorexigenic hypothalamic neurons in offspring of treated and untreated diabetic mother rats. Brain Res 2005; 1031: 276-283.
45. Batterham R, Ffytche D, Rosenthal J, et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007; 450: 106-109.